John Lewicki

Chief Tech/Sci/R&D Officer presso MEREO BIOPHARMA GROUP PLC

Patrimonio netto: 2 402 $ in data 31/03/2024

72 anni

Health Technology

Consumer Services

Posizioni attive di John Lewicki

Società	Posizione	Inizio	Fine
MEREO BIOPHARMA GROUP PLC	Chief Tech/Sci/R&D Officer	01/07/2020	-

Società	Posizione	Inizio	Fine
ONCOMED PHARMACEUTICALS INC	Director/Board Member	19/03/2018	23/04/2019
	Chief Executive Officer	19/03/2018	23/04/2019
	Chief Tech/Sci/R&D Officer	01/01/2004	21/02/2018
	President	21/02/2018	23/04/2019
Scios, Inc. Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA.	Chief Tech/Sci/R&D Officer	-	-
	Corporate Officer/Principal	01/01/1983	01/01/2000

University of California San Diego

Doctorate Degree

Distribuzione geografica

Stati Uniti	4
Regno Unito	2

Posizioni

Settori

Health Technology	4
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
MEREO BIOPHARMA GROUP PLC	Health Technology

Aziende private	2
Scios, Inc. Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA.	Health Technology
OncoMed Pharmaceuticals, Inc. OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA.	Health Technology

Aziende private

Health Technology